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Objective. To investigate the clinicopathological features and outcome of glomerulonephritis with crescents among Saudi children.
Method. This is a retrospective study of cases of crescentic glomerulonephritis (CrGN) seen over a 9-year period. Histological
features and renal function were recorded. Results. Thirty-seven cases were enrolled. The mean percent of glomeruli with crescents
was 39% (±19). Lupus nephritis (LN) was the commonest etiology (54.1%). At presentation, the serum creatinine (SCr) was 218.2
(±174.3)umol/l,and57.1%ofthecaseshadnephroticrangeproteinuria.Bytheendoftheobservationperiod,SCrdroppedto81.0
(±67.7) umol/l (P = 0.001). Worsening renal function was associated with younger age (P = 0.002), non-LN etiology (P = 0.01),
more crescents (P = 0.019), and ATN (P = 0.05). At the end of the followup, more patients in the LN group were dialysis-free
(P = 0.017) and had improved renal function (0.01) than in the non-LN group. Using multivariate analysis, the only independent
factor found to predict need for dialysis or change in SCr level was percent of globally sclerosed glomeruli (P = 0.034). Conclusion.
LN is the main cause of CrGN in our cohort of children. The LN group had less globally sclerorsed glomeruli and better renal
prognosis than the non-LN group.
1.Introduction
Of all renal biopsies done in the pediatric population, 5%
to 15% are due to crescentic glomerulonephritis [1, 2]. This
variation in frequency is most likely due to diﬀerences in the
indication criteria. Use for the biopsy.
The criteria for the number of aﬀected glomeruli re-
quired for the diagnosis of crescentic glomerulonephritis
vary from 20 to 75% in various pediatric studies [3]. The
reports on crescentic glomerulonephritis in children are very
few and most of these reports are over a decade old [2, 4–6].
Most of these reports suggest that the comments cause for
crescentic glomerulonephritis in children is postinfectious
glomerulonephritis and that the prognosis is generally poor.
There are no previous reports on crescentic glomeru-
lonephritis or lupus nephritis in Saudi children. We under-
took this study to assess the etiology, presentation, and
outcome in Saudi children with biopsy-proven crescentic
glomerulonephritis.
2. Methods
This is a retrospective descriptive study. All the renal biopsies
in children below the age of 18 years done over a 9-year
period (2001–2009) which showed crescents in >20% of the
glomeruli were included. All biopsies were reviewed by light
microscopy, immunoﬂuorescence, and electron microscopy
and reviewed by a North American trained nephropatholo-
gist blinded to the patient outcome. The etiology was ascer-
tained by clinical assessment, serological tests (including
anti-DNA, ASO titer, anti-GBM, ANCA, C3, and C4) and
histologicalcriteria.ThediagnosisofSLEinthepatientswith
this entity was made based on the American Rheumatologic
Association criteria of SLE [7]. The histological ﬁndings2 ISRN Pediatrics
Table 1: Comparing Lupus nephritis with other forms of crescentic GN (demographic and clinical data).
All (n = 37) LN (n = 20) (mean ± Std) Non LN (n = 17) (mean ± Std) P
Females (%) 57.5% 80% 70.6% 0.5
Age (years) 13.2 (±5.6) 15.8 (±3.0) 9.4 (±4.7) 0.000
SCr at biopsy (umol/l) 218.2 (±174) 243.7 (±178.1) 173.5 (±169.2) 0.38
SCr at follow up (umol/l) 81 (±67) 74.4 (±19.3) 94.3 (±119.1) 0.54
Baseline proteinuria (gms) 5.1 (±6.4) 5.4 (±7.7) 4.6 (±3.9) 0.8
Last proteinuria (gms) 2.7 (±6.9) 3.5 (±8.6) 1.5 (±2.3) 0.5
% Change in SCr −28.4 (±48) −44.7 (±37.6) −7.1 (±53.8) 0.06
Change in proteinuria −16.7 (±12.8) −11.3 (±132.3) −24.6 (±129.3) 0.8
Table 2: Baseline renal details.
All lupus Nonlupus P
Acute renal failure 68.20% 71.40% 50.00% 0.30
Needed dialysis 12.50% 8.30% 27.30% 0.04
% with proteinuria 95.60% 92.90% 100% 0.40
% with nephrotic
proteinuria 52.20% 50.00% 55.60% 0.80
recorded included the number of glomeruli with crescents
present, global and segmental glomerular sclerosis, acute tu-
bularnecrosis(ATN)andinterstitialinﬁltrate.Lupusnephri-
tis was diagnosed and classiﬁed based on the ISN/RPS clas-
siﬁcation [8]. The activity and chronicity, in cases of lupus
nephritis, were scored based on previously described meth-
ods [9].
The serum creatinine levels and 24-hour proteinuria and
serologicaltestswererecordedatthetimeofbiopsyandatthe
end of followup period. The primary outcome investigated
was renal outcome.
Descriptive statistics were generated. The baseline and
endoffollowupmeanswascomparedusingtwo-tailedpaired
t test and non-paired continuous data was compared using
independent t test and one way ANOVA for comparing
multiple continuous data Signiﬁcance of changes for cate-
gorical data (e.g., gender, etiology) was assessed using Chi-
Square test or Kruskal Wallis. The risk and prognostic factors
for diﬀerent variables were analyzed by linear multivariate
regression when the dependent factor is continuous and by
logistic multivariate regression when it is categorical. A P
value<0.05wasconsideredsigniﬁcant.Allstatisticalanalyses
were carried out using the SPSS 17 software package. The
local Institutional Review Board approved the study.
3. Results
Thirty-seven children had biopsyproven crescentic glomeru-
lonephritis. The mean followup period from the time of
biopsy was 30.9 (±22) months.
The causes of crescentic glomerulonephritis was lupus
nephritis in 20 (54.1%), postinfectious glomerulonephritis
in 6 (16.2%), immune complex glomerulonephritis in 5
(13.5%), pauci immune glomerulonephritis in 3 (8.1%), and
others in 3 (8.1%). The mean age in the whole group, was
Table 3: Final renal details.
At follow-up
Lupus Nonlupus P
Dialysis dependent 0% 36.4% 0.017
Improved 100% 60% 0.01
Proteinuria 3.6 (±8.6) 1.5 (±2.3) 0.5
Change in SCr (umol/l) (−) 44.7% (−) 7.1% 0.06
Change in proteinuria
(gms/24 hours) (−) 11.3 (−) 24.6 0.8
13.2 (± 5.6) years, 15.8 (± 3.0) in the lupus nephritis group
and9.4(±4.7)yearsinthenonlupusgroup(P = 0.000).The
females comprised 75.7% of the whole group and 80% of the
lupus nephritis group (P = NS). (Table 1)
At the time of biopsy, 68.20% had acute renal failure,
12.5% required dialysis, 95.6% had proteinuria and 52.2%
had nephrotic range proteinuria, (Table 2). There were
no signiﬁcant diﬀerences between the lupus nephritis and
nonlupus nephritis groups in the prevalences of acute renal
failure or proteinuria. However, there were over three times
as many patients in the non-lupus nephritis group who
required dialysis at biopsy (Table 2). In the group as a whole,
theserumcreatinineand24-hoururineexcretion,atthetime
of biopsy, were 218.2 (±174.3)umol/l and 5.1 (±6.4)gms,
respectively. By the end of the follow-up period, these values
dropped81.0(±67.7)umol/l(P = 0.001)and2.7(±6.9)gms
(P = 0.008), respectively.
At the end of the followup period, the lupus nephritis
group fared better than the nonlupus nephritis group in that
less patients required dialysis (P = 0.017) and more patients
showed improved renal function (P = 0.01). However, there
was no signiﬁcant diﬀerence in end of follow-up proteinuria
(P = 0.5) (Table 3)
Amongthelupusnephritisgroup,themeanactivityscore
was 11.4 (±4.3) and the mean chronicity score was 3 (±1.2).
Table 4 showsthattherewerenosigniﬁcant diﬀerences in the
histological ﬁndings between the lupus and nonlupus groups
except that there were more globally sclerorsed glomeruli in
the non-lupus group (P = 0.05). Although the non-lupus
group had higher percentage of glomeruli with crescents,
higher interstitial ﬁbrosis/atrophy, acute tubular necrosis,
and vasculopathy than the lupus nephritis group, none of
these reached signiﬁcant levels (Table 4).ISRN Pediatrics 3
Table 4: Comparing lupus nephritis with other forms of crescentic GN (histological ﬁndings).
LN (n = 20) (mean ± Std) Non-LN (n = 17) (mean ± Std) P
No of glomeruli in the biopsy 24.9 (±11.4) 26.8 (±11.5) 0.6
Globally sclerorsed glomeruli (%) 3.9 (±5.1) 13.8 (±22.2) 0.05
Glomeruli with crescents (%) 36 (±13) 42 (±24) 0.35
% glomeruli with BM thickening 30% 17.6% 0.4
% glomeruli with mesangial cellularity 15% 17.6% 0.8
% glomeruli with mesangial matrix expansion 35% 35.3% 0.98
% glomeruli with Interstitial ﬁbrosis/atrophy 5% 11.8% 0.4
% glomeruli with ATN 25% 41.2% 0.3
% glomeruli with s vasculopathy 0% 11.8% 0.1
Table 5: Factors predicting renal function.
Renal function improved Renal function worsened P
Age in years 13.5 (±5.6) 8.5 (±1.3) 0.002
Globally sclerorsed (GS) glomeruli (%) 6.4 (±9.3) 9.3 (±14) 0.3
Percent of glomeruli with crescents 35 (±17) 59 (±18) 0.019
Percent change in proteinuria −15.2 (13.8) −8.3 (±12) 0.2
Female gender 85% 75% 0.6
Lupus etiology 70% 0% 0.01
Signiﬁcant glomerular inﬁltrate 35% 75% 0.1
Signiﬁcant mesangial cellularity 10% 25% 0.4
Signiﬁcant mesangial matrix expansion 30% 25% 0.8
Signiﬁcant interstitial ﬁbrosis/atrophy 10% 0% 0.2
Signiﬁcant acute tubular necrosis 25% 75% 0.05
Signiﬁcant vasculopathy 5% 25% 0.02
Table 6: Correlation with % change in serum creatinine.
Factor R P
% Gloms with Crescents 0.98 0.03
Baseline SCr 0.4 0.20
Baseline Proteinuria at biopsy 0.4 0.20
% change in proteinuria 0.33 0.22
In the group as a whole, the factors associated with wor-
sening renal function were younger age (P = 0.002), being
non-lupus nephritis (P = 0.01), higher percent of glomeruli
with crescents (P = 0.019), presence of more ATN on biopsy
(P = 0.05), and more vasculopathy (P = 0.02) (Table 5).
We removed the extra right delimiter after the high-
lighted part. Please check.
Usinglogisticmultivariateanalysis,theonlyindependent
factors found to predict need for dialysis were percent of
globally sclerorsed glomeruli (P = 0.034). Baseline protein-
uria or SCr, gender, number of glomeruli with crescents, on
the other hand, did not impact prognosis. Using linear re-
gression multivariate analysis, SCr, protein excretion, and
activity score at biopsy did not inﬂuence change in SCr or
ﬁnal SCr during the followup period.
No correlation as found between the changes in serum
creatinine over the observation period and any of the fol-
lowing parameters: baseline SCr or proteinuria but there was
a signiﬁcant correlation with % of glomeruli with crescents
(r = 0.98, P = 0.03) (Table 6).
4. Discussion
There are very few papers on crescentic glomerulonephritis
in children. This is the ﬁrst paper describing Saudi children
withcondition.Oneofthemoststrikingdiﬀerenceswenoted
from other reports is in the etiology of crescentic glomeru-
lonephritis. In our group, lupus nephritis and postinfectious
GN contributed 54.1% and 16.2% of the cases, respectively.
In a recent report on Indian children, lupus nephritis
contributed only 9.1% with the main etiology being post
infectious GN (36.8%) [1]. Table 7 compares our ﬁndings
to reports from IUSA [4], India [1], France [5], and UK
[6] on crescentic glomerulonephritis in the pediatric group.
The most striking diﬀerences can be seen in the etiology and
frequency of renal loss. In our group, the etiology of the
glomerulonephritis was lupus nephritis in over 50% of the
cases, whereas in the other groups less than 10% of the cases
were due to lupus nephritis. We also observed a better renal
outcome in our patients. This may simply be related to the
less severe baseline renal impairment (Table 7).
In our study, the lupus nephritis group had a better
prognosis despite higher baseline serum creatinine. More
patients in this group were dialysis-free by the end of the
observation period (P = 0.017) and showed improvement4 ISRN Pediatrics
Table 7: Comparing our ﬁndings to 4 other reports on crescentic GN among children.
Dewan et al. [1]
(n = 22)
No author [4]
(n = 50)
Jardim et al. [6]
(n = 30)
Niaudet and
Levy [5]
(n = 41)
This paper
(n = 37)
Mean age (years) 12.3 10.1 9.5 13.2
M:Fratio 1.9:1 1:1.5 1:1.3 1:1.4
Renal loss (required dialysis) 45.5 48% 30% 16.7%
Presence of hypertension 95.5% 51% 63.3% 55%
Presence of Proteinuria 78% 95.5%
Baseline renal function Mean SCr 484 GFR < 66% GFR < 30 in 73.3%
(mean SCr 457) Mean SCr 218
Lupus Nephritis (%) 9.1 18 2.4 3.3 54.5
I m m u n ec o m p l e xG N( % ) 59 56 59.9 75.3 21.6
Table 8: Comparing our ﬁndings to 3 other reports on lupus nephritis among children.
Hobbs et al. [10] Bogdanov´ ıc et al. [11]W o n g e t a l . [ 12] This paper
Mean age (years) 14.5 14.5 15.8
M:F ratio 1:19 15:1 4:1
Class 4 33.3% 64% 53. −% 95%
Renal loss (required dialysis) 0% 80% had complete or partial remission 3.1% 0%
Nephrotic 57.1% 40% 60% 50%
Baseline renal function 33.3% Dx; SCr 237 20% had renal impairment SCr 244
in renal function by the end of the observation period
(0.01). This might reﬂect the less percent of glomeruli
with crescents and those with global sclerosis in the LN
group. Similar good renal outcome was reported by others
[10–12]( Table 8). In one study, [10] none of the children
with lupus nephritis required dialysis which is similar to
our ﬁnding (Table 8). Even the patients with Class IV lu-
pus nephritis showed signiﬁcant improvement in renal
function [10]. Like us Bogdanovi´ c et al. found that gender
and baseline renal function was not associated with worse
renal function. However, unlike us, they found that that the
presence of nephrotic syndrome was associated with worse
renal prognosis.
In a recent study on adults with crescentic lupus nephri-
tis, the renal prognosis was also found to be good with only
4.3% developing end-stage renal failure at the end of a mean
follow up period of 56 months [13].
Frequency and type of renal involvement in SLE is
diﬀerent in diﬀerent ethnic groups being, for example,
higher in Afro-Americans and Hispanics that Caucasians in
USA [14]. Moreover, in Afro-Americans and Hispanics, the
prognosis of LN seems to be worse than in Caucasians [14].
Scanty reports for KSA would suggest that there is a high
prevalence of LN among Saudi patients with SLE [15].
5. Conclusion
In Saudi children, the commonest cause of crescentic glom-
erulonephritisbyfarislupusnephritis.Thefactorsassociated
withworseningrenalfunctionwereyoungerage(P = 0.002),
higher percent of glomeruli with crescents (P = 0.019), and
the etiology being due to non-lupus nephritis (P = 0.01).
The other factors constitute more evidence of ATN and vas-
culopathy (P = 0.02) on histology (P = 0.05). Others have
also found that pathologic features associated with a poor
prognosis included predominance of large crescents (P =
0.004), global glomerular sclerosis, interstitial ﬁbrosis and
tubular atrophy [4].
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